SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 84 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $3,341,000 | +35.4% | 34,261 | +28.8% | 0.04% | +34.5% |
| Q4 2014 | $2,468,000 | +40.2% | 26,593 | +3.9% | 0.03% | +26.1% |
| Q3 2014 | $1,760,000 | -44.9% | 25,588 | -16.0% | 0.02% | -43.9% |
| Q2 2014 | $3,193,000 | -10.4% | 30,472 | -29.1% | 0.04% | -8.9% |
| Q1 2014 | $3,565,000 | +269.4% | 42,969 | +188.2% | 0.04% | +221.4% |
| Q4 2013 | $965,000 | -25.4% | 14,911 | -27.1% | 0.01% | -54.8% |
| Q3 2013 | $1,294,000 | +146.0% | 20,443 | +63.2% | 0.03% | +210.0% |
| Q2 2013 | $526,000 | – | 12,524 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
| BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
| SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
| Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
| Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
| ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
| PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
| FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
| Tradeworx Inc. | 2,936 | $308,000 | 0.25% |